Simon Bradley T, Scallan Elizabeth M, Siracusa Carlo, Henderson Amy, Sleeper Meg M, Larenza Menzies M Paula
Department of Clinical Sciences, Ross University School of Veterinary Medicine, PO Box 334, Basseterre, St. Kitts (Simon, Scallan); Department of Clinical Sciences, Mathew J. Ryan Veterinary Hospital, Veterinary School, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA (Siracusa, Henderson, Sleeper, Menzies).
Can Vet J. 2014 Sep;55(9):875-85.
This study evaluated whether acepromazine or methadone reduced behavioral parameters, overall excitement, and activity associated with midazolam administration to healthy dogs. Dogs received midazolam (M) alone [M: 0.25 mg/kg body weight (BW)] or with methadone (MM) (MM: 0.75 mg/kg BW) or acepromazine (MA) (MA: 0.03 mg/kg BW) or saline (S) solution alone, all intramuscularly. Two blinded observers evaluated behavioral parameters using video recordings 30 min before and after injection of drugs. Accelerometery was used to evaluate "total activity counts" (TAC) at baseline and post-treatment. Post-treatment excitement scores were significantly higher in M and MA compared to baseline, M and MM compared to S, and M compared to MA. Behavioral parameters showed significantly higher proportions of "pacing" post-treatment in all groups receiving midazolam, and "restlessness," "chewing/licking," and "sniffing" in M. No significant differences were found for TAC at baseline and post-treatment. Midazolam-induced paradoxical behavioral changes (excitation, panting, pacing, restlessness, licking/chewing, and vocalization) were not prevented by acepromazine or methadone in healthy dogs.
本研究评估了乙酰丙嗪或美沙酮是否能降低给健康犬注射咪达唑仑时的行为参数、整体兴奋度及活动水平。犬只分别单独接受咪达唑仑(M组:0.25毫克/千克体重)、或与美沙酮联合使用(MM组:0.75毫克/千克体重)、或与乙酰丙嗪联合使用(MA组:0.03毫克/千克体重)、或单独接受生理盐水(S组),均通过肌肉注射给药。两名盲法观察者在注射药物前后30分钟使用视频记录评估行为参数。使用加速度计在基线和治疗后评估“总活动计数”(TAC)。与基线相比,M组和MA组治疗后的兴奋评分显著更高;与S组相比,M组和MM组治疗后的兴奋评分显著更高;与MA组相比,M组治疗后的兴奋评分显著更高。在所有接受咪达唑仑的组中,治疗后行为参数显示“踱步”的比例显著更高,在M组中“烦躁不安”“咀嚼/舔舐”,以及“嗅探”的比例显著更高。基线和治疗后的TAC未发现显著差异。在健康犬中,乙酰丙嗪或美沙酮不能预防咪达唑仑诱导的反常行为变化(兴奋、喘气、踱步、烦躁不安、舔舐/咀嚼和发声)。